U.S. Oil and Gas Stock News

Investors may be wondering if Marathon Petroleum at US$241.73 is still offering value after such a strong run, or if most of the opportunity is already reflected in the price. The stock has seen a 2.6% pullback over the last 7 days, alongside gains of 14.0% over 30 days, 46.4% year to date, and 92.0% over the past year, so recent returns may be changing how investors view its risk and reward profile. Recent coverage has focused on Marathon Petroleum as an established US refiner with a long...

UiPath (PATH) drew fresh attention after expanding Chief Technology Officer Raghu Malpani’s remit to Chief Product and Technology Officer, while also unveiling new agentic AI solutions aimed at finance, retail, manufacturing, and financial services customers. See our latest analysis for UiPath. Even with this fresh push into agentic AI and the expanded product leadership role for Raghu Malpani, UiPath shares have seen mixed momentum. The 1-day share price return is 2% and the 90-day share...

Yum! Brands (YUM) has drawn fresh attention after appointing Kathleen K. Oberg, former Chief Financial Officer and Executive Vice President, Development of Marriott International, to its Board of Directors, effective April 1, 2026. See our latest analysis for Yum! Brands. The appointment of Kathleen Oberg comes as Yum! Brands trades at US$156.09, with a 1 day share price return of 1.55% and a 90 day share price return of 3.72%. The 1 year total shareholder return of 1.46% and 5 year total...

Investors may be wondering whether ServiceNow's current share price still reflects its long term potential, or if recent moves have created a more attractive entry point. The stock last closed at US$102.0, with returns of a 1.6% decline over 7 days, a 9.9% decline over 30 days, a 30.8% decline year to date, and a 34.1% decline over 1 year. This compares with a 7.8% gain over 3 years and a 2.7% decline over 5 years. Recent coverage has focused on how software names like ServiceNow are being...

Regeneron Pharmaceuticals and Sanofi recently received approval from Japan’s Ministry of Health, Labour and Welfare for Dupixent to treat adults with moderate-to-severe bullous pemphigoid, backed by a pivotal LIBERTY-BP-ADEPT trial showing over four times more patients on Dupixent achieved sustained remission versus placebo through Week 36. This decision adds a seventh Japanese indication for Dupixent and introduces the first targeted, non-immunosuppressant therapy for a rare, relapsing skin...

Recent share performance and business snapshot With no single headline event driving trading, Reynolds Consumer Products (REYN) has drawn attention after a month return of about an 11% decline and a past 3 months return near an 8% decline. At a recent close of $21.17, the company carries a market value of about $4.5b and reports annual revenue of $3.72b and net income of $301.0m across its four operating segments. See our latest analysis for Reynolds Consumer Products. Reynolds Consumer...

Recent reports describe multiple criminal incidents involving Lyft drivers, including alleged kidnapping, sexual battery, and carjacking across several U.S. cities. These cases have surfaced after the consolidation of federal multidistrict litigation focused on rider safety, raising fresh questions about current safeguards on the platform. The incidents are drawing renewed attention to Lyft’s legal exposure, brand risk, and the effectiveness of its recent safety measures. Lyft, traded as...

Why analyst sentiment around Ouster (OUST) is shifting Ouster (OUST) is drawing fresh attention as analysts raise earnings and revenue expectations ahead of the upcoming report. This shift in sentiment is being cited as a key driver of recent investor interest. See our latest analysis for Ouster. Recent trading reflects a mixed picture for Ouster, with a 1 day share price return of 4.67% and a 7 day gain of 0.93%, set against a 30 day share price return of 10.27% and a year to date share...

Recent analyst commentary on AppLovin (APP) has focused on its AI powered adtech products, its expansion efforts beyond mobile gaming, and feedback that recent share price weakness appears disconnected from the company’s reported business execution. See our latest analysis for AppLovin. Despite upbeat commentary around Axon and newer tools, the share price has moved sharply lower in recent months, with a 30 day share price return of 12% and a 90 day share price return of a 38% decline, even...

Kosmos Energy (NYSE:KOS) reported a disappointing Q4 2025. The company set targets for FY 2026 that include 15% production growth. Management is aiming to lower operating costs by 20% in FY 2026. The company is also targeting at least a 10% reduction in debt over the year. Kosmos Energy focuses on offshore oil and gas projects, so production volumes, cost control, and balance sheet strength are key drivers of its business. After a weaker Q4 2025, the newly outlined 2026 goals provide a...

Recent performance snapshot for Astec Industries (ASTE) Astec Industries (ASTE) has attracted attention after a 2.0% decline in the latest session, even as the stock shows a 3.7% gain over the past week and a 75.5% total return over the past year. See our latest analysis for Astec Industries. The recent 1 day share price decline and 11.1% 1 month share price pullback sit against a stronger backdrop, with a 23.4% 90 day share price return and 75.5% 1 year total shareholder return pointing to...

In its latest quarter, HEICO reported earnings per share of $1.35, above forecasts, as its Flight Support Group grew parts and Repair and Overhaul sales by 13% and closed the US$441 million Axillon acquisition, adding about US$125 million in revenue. This combination of an earnings beat, broad-based aftermarket growth, and a sizeable acquisition underscores how HEICO is expanding both scale and revenue diversity. Next, we’ll examine how the stronger Flight Support performance and Axillon...

What the latest earnings and guidance tell you Beyond Meat (BYND) is back in focus after its delayed fourth quarter and full year 2025 results, alongside fresh first quarter 2026 revenue guidance and an after hours share price reaction that caught many investors' attention. For the fourth quarter of 2025, Beyond Meat reported sales of US$61.59 million, compared with US$76.66 million a year earlier, and a net income of US$409.85 million versus a net loss of US$44.86 million in the prior year...

Stock split and upcoming sector event draw attention Piper Sandler Companies (PIPR) has just implemented a four-for-one forward stock split, with trading beginning on a split-adjusted basis, a move that can influence liquidity and investor interest. See our latest analysis for Piper Sandler Companies. The stock split arrives as Piper Sandler’s share price sits at $77.83, with recent momentum reflected in a 1.6% 1 day share price return and a 3.7% 7 day share price return. The 1 year total...

Wondering whether RTX at around US$196 per share still offers value, or if most of the opportunity is already priced in? This article walks through that question in plain terms. The stock has delivered a 53.2% return over the last year and 113.3% over three years, with a 4.8% year to date move, a 1.7% gain over the last week and a 5.0% decline over the last month that may have changed how some investors view its risk and reward trade off. Recent headlines around RTX have focused on long term...

AAR (NYSE:AIR) has secured a new long-term logistics support contract for the U.S. Navy and Marine Corps C-40A aircraft. The agreement expands AAR's government services backlog and adds to previously announced Air Force pallet work. The contract covers multi-year maintenance and support services, increasing AAR's exposure to recurring defense-related revenue. AAR focuses on aviation services, including maintenance, repair, and logistics support for both commercial and government customers...

Goldman Sachs Group (GS) is back in focus after regulators revised the Basel III framework, easing capital requirements for major banks, while commentary points to a projected pickup in mergers and acquisitions activity in 2026. See our latest analysis for Goldman Sachs Group. Goldman Sachs shares recently caught a bid on the Basel III revision and expectations for heavier M&A pipelines. While the 90 day share price return of 5.61% is weak, the 1 year total shareholder return of 72.31% and 5...

In March 2026, Intapp announced that Am Law 200 firm Buchanan Ingersoll & Rooney migrated Intapp Time to the cloud and adopted Intapp Terms to modernize timekeeping and strengthen compliance with client guidelines across matters. This win underscores growing demand among large professional services firms for AI-enabled, compliance-focused billing tools that streamline workflows and reduce manual data entry. We’ll now examine how Buchanan’s adoption of Intapp’s AI-powered cloud timekeeping...

In the recent past, Capital Southwest reported a very strong quarter, beating analysts’ revenue and EPS estimates and originating about US$244 million of new and follow-on investments across eight new and 16 existing portfolio companies. This performance placed Capital Southwest among the better-performing specialty finance names for the quarter, underlining healthy deal flow and active portfolio deployment. Now we’ll explore how this stronger-than-expected quarter, particularly the US$244...

Event context and recent share performance Kinsale Capital Group (KNSL) has recently drawn investor attention after a period of weaker share performance, with the stock showing a 12% decline over the past month and a similar move over the past 3 months. See our latest analysis for Kinsale Capital Group. Against this recent pullback, Kinsale Capital Group’s 1 year total shareholder return of a 30.7% decline contrasts with a 3 year total shareholder return of 13.26% and a 5 year total...

In late March 2026, reports suggested the FDA may delay authorization of certain oral nicotine products, including those Turning Point Brands has pending, as agency scientists weigh risks to new users and children. This hesitancy introduces fresh regulatory uncertainty around modern oral pouches, a category that has become central to Turning Point Brands’ growth plans. Next, we’ll examine how the potential for longer FDA approval timelines could reshape Turning Point Brands’ previously...

Multiple securities fraud lawsuits have been filed against Corcept Therapeutics (NasdaqCM:CORT), alleging the company misled investors about FDA concerns and trial efficacy for relacorilant. Plaintiffs claim Corcept did not fully disclose FDA reservations about the adequacy of clinical data before a Complete Response Letter declined approval for a specific indication. The FDA decision was followed by a sharp share price drop and a wave of class action filings from several law firms. The...

If you are wondering whether Unum Group's current share price reflects its underlying value, this breakdown aims to put the recent numbers and valuation signals into clear context. The stock last closed at US$74.17, with returns of 5.0% over 30 days, a 4.0% decline year to date, and a 4.2% decline over the past year. The 3 year and 5 year returns sit at 107.2% and 219.5% respectively. Recent coverage of Unum Group has focused on its position within the US insurance sector and how investors...

What is driving MasTec’s latest surge in attention? Recent analyst upgrades, heavier institutional buying, and a run of positive brokerage ratings have pushed MasTec (MTZ) into the spotlight. Many investors are reassessing the contractor’s infrastructure focused business model and recent share performance. See our latest analysis for MasTec. Their recent 0.7% 1 day share price return, 9.6% 7 day share price return, and 47.7% year to date share price return, alongside a 200.2% 1 year total...